Miracor Medical Systems GmbH
There is No Better Way to Cure a Broken Heart ®
More than 350,000 severe heart attack patients have poor microcirculation even after a successful stent/PCI procedure. These heart attack patients are younger (35-65 years old) and improving their outcome is essential to reduce health care costs. Miracor has developed the PICSO technology to address this big unmet clinical need, has obtained CE-mark and is currently conducting post-market clinical trials in acute coronary syndrome patients.